Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Clinical trial NCT01302600 · COMPLETED

Trial details

NCT number: NCT01302600
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy Type II Spinal Muscular Atrophy Type III Non Ambulant

Start date: 2010-11-01
Primary completion: 2013-10-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.